Antibodies derived from llamas have been shown to neutralise the SARS-CoV-2 virus in lab tests, UK researchers announced today. The team involves researchers from the Rosalind Franklin Institute, Oxford University, Diamond Light Source and Public Health England. They hope the antibodies – known as nanobodies due to their small size – could eventually be developed as a treatment for patients with severe COVID-19. The peer reviewed findings are published in Nature Structural & Molecular Biology.
- COVID-19 lockdown reduced mental health, sleep, exercise
- Coating implants with ‘artificial bone’ to prevent inflammation
- COVID-19 anxiety linked to body image issues
- Medical minds meet to develop novel treatment for one patient’s immune system defect
- Report calls for easing access, improving home health for older adults